Conflicts of interest

Christian Vogelberg reports consulting fees and/or payment or honoraria for lectures, presentations or speakers bureaus from Allergy Therapeutics, Bencard Allergie, Allergopharma, HAL Allergy, Stallergenes Greer, Novartis Pharma, LETI Pharma, DBV Technology, Aimmune, Sanofi Aventis, ALK-Abelló, Memberships: AeDA, GPA, APPA, DGAKI, EAACI.
Ludger Klimek reports grants, institutional fees and/or institutional payment for expert testimony from Allergopharma, Viatris, Stallergenes Greer, GSK, Sanofi, Leti Pharma, HAL Allergy, ALK-Abelló, Quintiles, ASIT biotech, Lofarma, AstraZeneca, Inmunotek, Allergy Therapeutics, Cassella med, Novartis, Regeneron Pharmaceuticals, Roxall Medizin GmbH; Memberships: AeDA, DGHNO, Deutsche Akademie für Allergologie und klinische Immunologie, HNO-BV, GPA, EAACI.
Bernd Brüggenjürgen reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from IQVIA, outside the submitted work.
Marek Jutel reports consulting fees and/or payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Allergopharma, Stallergenes Greer, ALK Abelló, Chiesi, HAL Allergy, GSK; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: EAACI, Fundacja Centrum Walki z Alergia.